| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10042174 | HBV | ENSG00000077044.11 | protein_coding | DGKD | No | No | 8527 | Q16760 |
| TVIS30007914 | HIV | ENSG00000077044.11 | protein_coding | DGKD | No | No | 8527 | Q16760 |
| TVIS30007915 | HIV | ENSG00000077044.11 | protein_coding | DGKD | No | No | 8527 | Q16760 |
| TVIS30007916 | HIV | ENSG00000077044.11 | protein_coding | DGKD | No | No | 8527 | Q16760 |
| TVIS30052563 | HIV | ENSG00000077044.11 | protein_coding | DGKD | No | No | 8527 | Q16760 |
| TVIS20007555 | HPV | ENSG00000077044.11 | protein_coding | DGKD | No | No | 8527 | Q16760 |
| TVIS20043344 | HPV | ENSG00000077044.11 | protein_coding | DGKD | No | No | 8527 | Q16760 |
| TVIS20027380 | HPV | ENSG00000077044.11 | protein_coding | DGKD | No | No | 8527 | Q16760 |
| TVIS20066482 | HPV | ENSG00000077044.11 | protein_coding | DGKD | No | No | 8527 | Q16760 |
| TVIS44037926 | HTLV-1 | ENSG00000077044.11 | protein_coding | DGKD | No | No | 8527 | Q16760 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | DGKD |
|---|---|
| DrugBank ID | DB00144 |
| Drug Name | Phosphatidyl serine |
| Target ID | BE0002297 |
| UniProt ID | Q16760 |
| Regulation Type | |
| PubMed IDs | 17139284; 17016423; 11309392; 8626538 |
| Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Bregoli L, Baldassare JJ, Raben DM: Nuclear diacylglycerol kinase-theta is activated in response to alpha-thrombin. J Biol Chem. 2001 Jun 29;276(26):23288-95. Epub 2001 Apr 17.@@Sakane F, Imai S, Kai M, Wada I, Kanoh H: Molecular cloning of a novel diacylglycerol kinase isozyme with a pleckstrin homology domain and a C-terminal tail similar to those of the EPH family of protein-tyrosine kinases. J Biol Chem. 1996 Apr 5;271(14):8394-401. |
| Groups | Investigational; Nutraceutical |
| Direct Classification | |
| SMILES | CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC |
| Pathways | Phosphatidylcholine Biosynthesis PC(14:0/20:0); Phosphatidylcholine Biosynthesis PC(14:0/20:4(5Z,8Z,11Z,14Z)); Phosphatidylcholine Biosynthesis PC(15:0/20:3(8Z,11Z,14Z)); Phosphatidylcholine Biosynthesis PC(15:0/16:0); Phosphatidylcholine Biosynthesis PC(14:0/20:5(5Z,8Z,11Z,14Z,17Z)); Phosphatidylcholine Biosynthesis PC(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:0); Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:1(9Z)); Phosphatidylcholine Biosynthesis PC(14:0/20:2(11Z,14Z)); Phosphatidylcholine Biosynthesis PC(14:1(9Z)/22:2(13Z,16Z)); Phosphatidylcholine Biosynthesis PC(14:1(9Z)/24:0); Phosphatidylcholine Biosynthesis PC(14:0/15:0); Phosphatidylcholine Biosynthesis PC(15:0/14:0); Phosphatidylcholine Biosynthesis PC(15:0/20:4(5Z,8Z,11Z,14Z)); Phosphatidylcholine Biosynthesis PC(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)); Phosphatidylcholine Biosynthesis PC(14:0/20:1(11Z)); Phosphatidylcholine Biosynthesis PC(16:0/16:0); Phosphatidylcholine Biosynthesis PC(16:0/14:0); Phosphatidylcholine Biosynthesis PC(15:0/16:1(9Z)); Phosphatidylcholine Biosynthesis PC(14:0/22:5(4Z,7Z,10Z,13Z,16Z)); Phosphatidylcholine Biosynthesis PC(15:0/22:0); Phosphatidylcholine Biosynthesis PC(14:1(9Z)/14:0); Phosphatidylcholine Biosynthesis PC(15:0/20:1(11Z)); Phosphatidylcholine Biosynthesis PC(14:0/18:2(9Z,12Z)); Phosphatidylcholine Biosynthesis PC(14:0/14:0); Phosphatidylcholine Biosynthesis PC(14:0/16:1(9Z)); Phosphatidylcholine Biosynthesis PC(16:0/18:1(9Z)); Phosphatidylcholine Biosynthesis PC(15:0/18:0); Phosphatidylcholine Biosynthesis PC(16:0/14:1(9Z)); Phosphatidylcholine Biosynthesis PC(14:1(9Z)/18:3(9Z,12Z,15Z)) |
| PharmGKB | PA164768860 |
| ChEMBL | CHEMBL4297669 |
